MENU
GRDX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

GridAI Technologies (GRDX) Ownership - Who owns GridAI Technologies?

GridAI Technologies Corp, formerly known as Entero Therapeutics Inc, is a late clinical-stage biopharmaceutical company focused on the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
10.52M
P/E Ratio
N/A
Total Cash
2.52M
Projected Growth
N/A
Total Debt
1.07M
Revenue
N/A
Risk (Beta)
0.50
Dividend Yield
N/A
Total Cash/Share
0.75
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

GRDX
Capitalization
10.5M
P/E Ratio
N/A
Risk (Beta)
0.50
Dividend Yield
N/A
Total Cash
2.52M
Total Cash/Share
0.75
Total Debt
1.07M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
22.6M
P/B Ratio
0.47
Cash Flow
N/A
Earnings
-12.31
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
255
Current Ratio
2.62
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-3.6M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-14.46
Shares Held By Institutions
819K
Shares Outstanding - Current
3.36M
Total Liabilities
45.8M
Total Volume MTD
N/A
Value
1
Gain YTD
-32.833
View a ticker or compare two or three
GRDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details